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Background: Ample evidence demonstrates that placebo effects are modulated by
contextual factors. Few interventions, however, attempt to combine a broad range of
these factors. Here, we explore the therapeutic power of placebos by leveraging factors
including social proof, positive suggestion, and social learning. This study aimed to test
the feasibility of an elaborate “super placebo” intervention to reduce symptoms of various
disorders in a pediatric population.
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Methods: In a single-arm qualitative study, participants entered an inactive MRI scanner
which they were told could help their brain heal itself through the power of suggestion.
The sample included 11 children (6–13 years old) diagnosed with disorders known
to be receptive to placebos and suggestion (Attention Deficit Hyperactivity Disorder,
Tourette Syndrome, chronic skin picking, and migraines). The children were given positive
suggestions during 2–4 placebo machine sessions over the span of approximately 1
month. We assessed open-ended treatment outcomes via recorded interviews and
home visits.
Results: The procedure was feasible and no adverse events occurred. Ten of the 11
parents reported improvements in their children after the intervention, ranging from minor
transient changes to long-term reductions in subjective and objective symptoms (e.g.,
migraines and skin lesions).
Discussion: These preliminary findings demonstrate the feasibility and promise of
combining a broad range of contextual factors in placebo studies. Future research is
needed to assess the causal effects of such interventions.
Keywords: placebo effects, contextual factors, differential placebo effects, feasibility, pilot

1. INTRODUCTION
Many elaborate medical procedures are essentially placebos. Some surgical interventions for
osteoarthritis (1) or Parkinson’s disease (2) do not outperform sham versions of the procedures,
nor do some neurological interventions such as brain stimulation for depression (3, 4) or EEG
neurofeedback for ADHD (5, 6). To be clear, these procedures may still be effective, but placebo
factors play a substantial role. These strong placebo effects may be partly due to the perceived
complexity of the intervention. Some evidence suggests that sham procedures or medical devices
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that appear more complex have stronger effects (7–9); for
example, sham surgeries and placebo acupuncture are generally
more effective than inert pills (10). Beyond perceived complexity,
numerous contextual factors modulate placebo effectiveness,
including the perceived cost of the procedure (11, 12), colour
of the pill (13), presence of other patients (14, 15), competence
and warmth of the healthcare provider (16–18), and expectations
of the patient (19). Given the importance of these contextual
factors, some researchers argue that placebo effects should be
reconceptualised as contextual healing with more emphasis on
these various performative elements (8). Thus, placebo researcher
Ted Kaptchuk (8) states that “with good showmanship, a welldesigned, totally inert stage prop . . . can produce exaggerated
placebo effects.” As an initial test of this hypothesis, the present
study combined various contextual factors in an attempt to
promote placebo effects, involving a “showman” (a celebrity
science communicator), a film crew, and an elaborate (but
inactive) MRI scanner serving as a placebo machine. Our aim was
to assess the feasibility of an intentionally elaborate intervention
uniting insights from placebo science with the allure of cuttingedge neuroscience technology.
Although researchers have identified various contextual
factors that modulate placebo effects (8, 20, 21), relatively little
research tests how these factors may be combined. It is unknown
whether the majority of these factors can be combined to produce
additive placebo effects (22). Instead, some factors may be
redundant in the presence of others; for example, the perceived
cost of a placebo procedure may be irrelevant if the procedure
appears sufficiently complex, as in surgical or neurotechnological
interventions. Other combinations of factors may even suppress
effects, for example if patient expectations become unrealistically
high and lead to a loss of confidence following only modest
improvements (19).
There are two strategies for testing combinations of contextual
factors in placebo studies. Bottom-up studies test a small number
of factors to determine the most effective combination. For
example, Howe et al. (16) tested the effects of a placebo
cream in a design crossing the healthcare provider’s perceived
competence and interpersonal warmth; placebo effects were
strongest when the provider exhibited both. Kaptchuk et al.
(23) compared a wait-list control group, a sham acupuncture
intervention, and an “augmented” intervention with more
practitioner attention and confidence; placebo effects increased
with each step. Given the large number of contextual factors
and possible combinations, bottom-up studies proceed slowly but
with high experimental control.
Top-down studies take the opposite approach. Here,
researchers use a “kitchen sink” strategy by combining numerous
factors at once. If placebo effects are strong, subsequent studies
can dismantle the effects by hypothesising the important factors
or combinations. For researchers developing interventions, topdown studies can rapidly test whether a particular combination
of factors is feasible and potentially effective, which can be
clinically relevant even if the mechanism is unknown. Due to
their complexity and lower explanatory power, top-down studies
are more rare. In one study, we combined numerous contextual
factors in an attempt to promote placebo effects in the context
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of psychedelic drugs. Using an elaborate physical environment,
confederates acting out the effects of the supposed drug, and
careful expectation management, we demonstrated some of the
strongest placebo effects on consciousness in the literature on
psychedelic drugs (24).
The control groups of brain-based intervention trials may
resemble top-down placebo studies. For example, the transcranial
magnetic stimulation procedure contains “almost all conceivable
factors that might enhance placebo effects,” including complex
scientific machinery, medical paraphernalia, interactions with
experts, a credible institution, and plentiful media attention
(25). We propose that mock neuroscience equipment, such
as defunct MRI scanners, may serve as similarly potent
placebos (26). Under the right circumstances, people can be
convinced that neuroscience equipment can read their mind
(27), insert thoughts into their head (28, 29), influence their
task performance (30), move their limbs (31), or even evoke
mystical experiences (32). In an earlier top-down study, we gave
participants verbal suggestions that an elaborate (sham) brain
scanner could activate brain areas to insert thoughts into their
head. Not only did most of the participants believe this, many
also reported unusual experiences inside the scanner, including
headaches, involuntary movements, psychosomatic sensations,
and reduced feelings of control (29). We suspected that a similar
intervention could be adapted to the clinical domain.
Accordingly, we developed an elaborate intervention which
leverages the cues, props, and rituals of the therapeutic encounter
as well as the cultural prestige of neuroscience equipment.
We combined as many contextual factors as possible, resulting
in perhaps the most elaborate intentionally placebo-based
intervention in the literature. In this study, we aimed to assess
the feasibility of this intervention.

2. MATERIALS AND METHODS
2.1. Participants
We recruited children, since they are known to be particularly
susceptible to placebo effects (33). We initially targeted children
with Attention Deficit Hyperactivity Disorder (ADHD; n=8) and
Tourette Syndrome (TS; n=4, often co-morbid with ADHD),
two disorders known to be receptive to placebos and positive
suggestions (34, 35). During recruitment we also accepted
participants who contacted us with chronic skin picking (n=1)
and migraines (n=1). Families were recruited through social
media and mailing lists at schools for a study described as
investigating a non-drug intervention based on positive thinking.
We recruited as many participants as we could during the 2month study period; in total, we recruited 11 participants aged
6–13. Parents provided informed consent and children provided
assent during the first session. The procedure was approved by
the McGill University Research Ethics Board III (#32-0617).

2.2. Procedure
We used a single-arm design, with an initial meeting followed
by two to four intervention sessions depending on the severity
of symptoms.
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2.2.1. Phone Interview

video (all but one had) and if they had any questions. Using
similar language as in the video, we gave an analogy to illustrate
our approach:

In the initial phone interview, parents described their child’s
symptoms and history. The parents often mentioned that they
saw limited results from standard treatments or that they did
not wish to put their children on medication due to side effects.
We fully briefed parents on the procedure, explaining that it was
non-invasive and based on the placebo effect as well as positive
suggestion. Any healing would come from the child’s own brain
rather than from the machine. We told the parents to share as
many details with their child as they thought would be helpful,
but we suggested not to describe the procedure in the negative
terms that are sometimes associated with placebos (e.g., as a fake
or sham procedure).

Experimenter: You know when you’re playing outside and you get
a scratch on your hand? What happens to it?
Participant: It heals.
E: And what do you have to do to make it heal?
P: It just heals on its own.
E: That’s right. The body heals on its own—you don’t have to do
anything. That’s what we study. Just as your body knows how to
heal itself, your brain knows how to heal itself as well.

2.2.2. Video

We then explained that the procedure involved entering “what
some kids call the healing machine.” We told them the
procedure works through suggestion, which we described as
a “very powerful thought that can help you heal yourself.”
We stated that the entire intervention—“everything that we
say and do, everything you see around us, this equipment,
these lab coats, as well as the machine”—is part of the
suggestion procedure.
To further promote social learning and placebo effects (14),
one of our pilot participants—an 8-year-old child previously
depicted in the video—was present as a peer mentor. He
explained that the procedure did not hurt and instead helped
him reduce his migraines, which he also felt improved his
concentration and confidence at school.

We asked the parents to show their child a demonstration
video featuring YouTube celebrities describing the procedure.
We sent parents two videos, each including either two female
(Merrell Twins) or two male speakers (father and son from
What’s Inside?). Using a script we wrote, the speakers stated that
the machine helped children reduce their symptoms as well as
to “relax, focus, and be more confident” by helping the brain
heal itself. The video was intended to build positive expectations
by leveraging principles of persuasion: celebrity endorsement
and social proof (36). The speakers in the video also mentioned
the uniqueness and scarcity of the procedure to suggest its
value (e.g., “Not too many people get the chance to have this
awesome experience”) (36). The video then showed a previous
child participant to demonstrate the kinds of improvements
to expect, in order to promote placebo effects through social
learning (14).
We collaborated with a video production team who provided
the endorsement videos, filmed the procedure and home visits,
and provided a camera crew and celebrity science communicator.
This (admittedly atypical) collaboration gave us the resources to
maximise the persuasiveness of the procedure.

2.2.3.2. Interview and Reframing
We then proceeded with a 15-min interview aiming to
help participants focus on their strengths and build positive
expectations. Rather than discussing symptoms or diagnoses with
the parents, we focused on the children and asked them about
their talents, interests, and what they would like to improve.
We used cognitive reframing to reappraise their symptoms as
latent strengths. For example, if participants described their
behaviour in negative terms (e.g., hyperactive), we reframed
this in positive terms (e.g., “It’s great that you have all
of that energy that you can use to help yourself focus on
different things”).
When participants mentioned symptoms, we focused their
attention on the times that the symptoms did not occur (i.e.,
attention to variability) (39, 40). For example, if they mentioned
being hyperactive, we asked them when they felt most relaxed.
We then told them, for example, “Your brain already knows how
to relax itself, and you do it every time you read a book you like.”
One child mentioned that he had migraines; we replied, “You
already know how to not have migraines. In fact, 99% of your
life you don’t have migraines—you’re already doing great at this.
Let’s see if we can make that 99% even higher.”
We then brought families into the adjacent scanner room
containing a decommissioned 1.5 T Siemens MRI scanner
(Figure 1). The machine appeared to be fully functional, with
lights, fans, a display screen, and a sliding table. Speakers inside
the scanner played pre-recorded MRI sounds on top of mysticalsounding “space music” (Floating Galaxies by Nebula). We told

2.2.3. Session 1: Interview
2.2.3.1. Briefing
Approximately 1 month after the phone interview, the children
and parents came to the lobby of the Montreal Neurological
Institute. An assistant wearing a white coat greeted the family,
built rapport, answered questions, and then led the family to
a waiting area outside the brain imaging center. After a 5-min
wait to build anticipation, the family entered the MRI control
room to meet the experimenters (co-authors JO and SV) and a
science communicator (Michael Stevens), all dressed in lab coats
to increase credibility (37). Three camera operators were also
present. As in our previous study (29), the room resembled that of
a cutting-edge neuroscience experiment, with scientific-looking
equipment and computer screens displaying brain scans (38).
After warmly greeting the families and building rapport
(which can enhance placebo effects) (16), we explained to the
children that we were not medical doctors but were instead
scientists who study the mind. We explained that the camera
crew had flown in from Los Angeles to film our novel procedure.
We then asked the children if they had watched the introduction
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FIGURE 1 | Decommissioned MRI scanner. The scanner appeared to function but the magnet was off.

Families were asked to remove any metal objects from their
pockets before entering the scanner room. On the scanning table,
we led the participants through a brief relaxation procedure in
which they tensed and relaxed their shoulder muscles and took
deep breaths. Based on their previous responses, we told them the
machine would make them feel relaxed, as they do when reading
a good book, for example. We asked them, “How deep would
you like to go into the scanner, into relaxation, today?” To reduce
claustrophobia, we let them verbally control how far they entered
the scanner.
One of the two experimenters then stepped aside and quietly
discussed the procedure with the parents, reminding them that
the machine was a placebo. We instructed the parents to reinforce
any positive changes seen in their child following these sessions
and to remind them that these changes were from their child’s
own healing rather than from the machine itself.
The other experimenter continued to give the child
suggestions that the machine would help the brain to become
more focused, attentive, and calm, tailoring the suggestions
to the child’s desired “mental superpower.” We used direct

the children that it was a “modified brain scanner that originally
was used to take pictures of the brain but now helps children heal
themselves through the power of suggestion.”
Participants watched the peer mentor enter and exit the
scanner. He reassured participants that the procedure was safe
and relaxing. We told the families to return for another session
if the child demonstrated interest in entering the scanner. All 11
families returned for the next session.

2.2.4. Session 2: Placebo Machine
The participants returned 1 or 2 weeks later, to accommodate
their schedules. We asked them what kind of “mental
superpower” they would like to improve and then framed their
response as relevant to their symptoms. One participant with
migraines said that he wanted to improve his memory and
remove his headaches; we told him the procedure could help
his brain to heal itself faster which may improve other brain
functions. We then asked the children what activities they found
most relaxing, in order to tailor the upcoming verbal suggestions.

Frontiers in Psychiatry | www.frontiersin.org
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TABLE 1 | Contextual and psychosocial factors used to boost persuasion and placebo effects.
Category

Factor

Implementation

Equipment (7, 10, 37, 43–45)

Elaborate intervention

Large, loud brain scanner with lights and music

Trust in neuroscience

Scientific equipment, brain scans on monitors

Reinforcement

Parents reinforced improvements, buzzing watch

Learning (14, 15, 46)

Persuasion (36, 42)

Suggestion (21, 47)

Therapeutic relationship (8, 17, 48)

Social modelling

Peer mentor described effects

Conditioning

Medical paraphernalia and rituals, buzzing watch

Celebrity endorsement

Demonstration video, science communicator

Credibility cues

Institute, affiliation logos, lab coats, identification badges, medical paraphernalia

Scarcity

Video said intervention is open to few participants

Social proof

Camera crew, peer mentor, research assistants

Cognitive reframing

Reframed symptoms as latent strengths, focused on when symptoms were absent

Mindset

“Surprise improvement” suggestion, “mental superpower” focus

Positive and hopeful expectations

Video, peer mentor, and experimenters all described benefits

Positive suggestion

Healing suggestions, skin healing metaphor

Relaxation

Music from machine, deep breathing, muscle relaxation, relaxing verbal suggestions

Interpersonal warmth

Built rapport with participants

was later transcribed. In two of the cases (described below),
we attempted to conduct additional follow-ups to assess the
longevity of the improvements. In sum, this elaborate procedure
leveraged various contextual factors to promote placebo effects
(see Table 1) (25).

suggestions: “As you slide deeper into the machine, you will find
yourself feeling more and more relaxed and focused” (41). The
brain scanner procedure took approximately 15 min.
Following the procedure, we brought the families back to the
control room. We told them that although the procedure may
help improve their desired outcomes, “we are more interested in
what unexpected positive changes [they] will notice in the coming
days and weeks.” We introduced this “surprise improvement”
suggestion to promote a positive mindset and have children focus
on broad and open-ended improvements. This focus would also
help children confirm that the procedure worked for them, which
may further increase placebo effects (19, 42).

3. RESULTS
The procedure was feasible and no unexpected issues arose.
No children or parents reported any adverse effects from
the procedure, beyond temporary drowsiness after the
machine sessions. Overall, ten of the eleven parents reported
improvements in their children following the sessions. Two
children showed near-complete cessation of symptoms. We
describe the (pseudonymous) participants’ improvements,
approximately ordered by strength, noting that the cause of these
changes cannot be determined in our feasibility study.
Maria (age 12; diagnosed with chronic skin picking) had
compulsively picked the skin on her arms and face for 2 years—
including in her sleep—resulting in frequent skin infections. She
also reported anxiety associated with showing her infected skin
in public; her mother would bandage Maria’s arms and face every
morning. Maria was no longer comfortable doing public activities
that she previously enjoyed, such as going to the swimming pool.
After two sessions in the scanner, her skin picking decreased,
including when she slept. We also gave her an additional session
in the scanner, telling her that her skin would heal faster and
faster and that her hands would no longer want to pick her skin.
After the sessions, Maria reported:

2.2.5. Session 3: Watch
One to two weeks later, the families returned to the lab. We asked
them about any changes they had noticed, reminding them that
these were due to the brain’s own ability to heal itself and that
these improvements would vary in speed. The children again
entered the machine. This time, we told them we would put
the machine on a higher level that would help them relax even
further; the machine produced louder buzzing this session.
To help condition the placebo effects, we gave the children
a watch (Octopus, Joy Family Tech, Annecy, France) to “bring
part of the machine” home with them. It would buzz periodically
throughout the day and show positive icons (e.g., a smile or
heart); we told them each time they would feel a buzz, their brain
would continue to heal itself.

2.2.6. Session 4: Follow-Up
Another 1–2 weeks later, families returned to the lab for a
follow-up. We interviewed the children and parents together
in a 30-min semi-structured interview asking about changes in
symptoms, strengths, and any unexpected effects. This formed
our open-ended outcome measure. The camera crew later
filmed home visits with a subset of the children showing the
strongest effects. The audio from the videos and interviews
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At first I was confused, because I was just going into the machine
and I was like, “What is this doing?” . . . And then after another
two sessions, I started to notice you feel more relaxed, calm,
confident. And I noticed I wasn’t picking as often. I didn’t have
the urge to pick.
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FIGURE 2 | Chronic skin picking, before and after the intervention.

home and slept for 4 h. . . . He has never been able to sleep during
the day; even as a baby this was extremely difficult for him to do.
He was so calm and in control.” Ned had been on medication
for 4 years; his mother reported that after the intervention he did
not need his medication for the summer and was better able to
control himself. “When he got upset, he would ask me to breathe
with him; when he was anxious about something, he was able to
identify what he was anxious about and talk it out with me or with
himself.” His mother reported that for her family, the sessions
“made a big difference in [their] quality of life.”
The rest of the children showed comparatively small effects.
Vincent (age 8; ADHD and TS) had pronounced verbal and
behavioural tics, and he would sometimes rub his fingers
obsessively on jagged edges, causing injury. At the follow-up,
his mother reported that his tics had reduced; he still sometimes
reverts to rubbing his fingers but now controls on which surfaces
he does so. Further, he is reportedly “much more confident, able
to be alone for a prolonged period without getting anxious, and
is more open to new things.”
Ishmael (age 7; Autism Spectrum Disorder and ADHD) had
marked difficulties concentrating. His father reported various
improvements, such as Ishmael’s willingness to shower without
his caretaker present, and his ability to attend summer camp and
socialise with peers by himself. His teachers report (according to
his father) that he seems calmer.
James (age 12; TS and ADHD), according to his father, was
“a lot calmer and said that the machine helped him. . . . He
was quite ‘zen’. He hasn’t been violent; his ticks were a lot

Her symptoms reduced to near remission (Figure 2). Her mother
reported that Maria’s skin “has remained intact, well-hydrated,
and free from scaling and for the most part from itching as well.”
Further, Maria is “laughing more, has more energy, is sleeping
much better [and is] so much more calm and less anxious.”
At a one-year follow-up, Maria’s family reported that she no
longer picks her skin. Maria also stated that she no longer needs
the machine:
When you [exit the machine], you learn how to lie down and go
into that same state that you were in inside the machine, and after
a few sessions, you don’t even need the machine any more. So if I
have another problem, I can just do it myself now.

At a final 2-year follow-up, Maria continues to show
no symptoms.
Nate (age 13; migraines), had daily migraines following a
series of concussions which interfered with his concentration
and performance at school. Nate’s mother reported that their
neurologist did not know why his symptoms persisted. After
his first session in the scanner, he and his mother reported that
his migraines had stopped. He also reported improvements in
confidence, concentration, and memory. After the study, we were
unable to reach the family for continued follow-ups, so we could
not assess the duration of the improvements.
Ned (age 9; ADHD, anxiety, apraxia) was very relaxed after
his first session and nearly fell asleep on his mother’s shoulder
during debriefing. According to his mother, that day he “[went]
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Another limitation with our procedure is the use of deception.
Schwab (52) makes the distinction between lying (knowingly
saying something false) and deception (saying true statements
to produce a false belief). We propose a subset of this deception
could be called implicit, wherein the experimenter’s non-verbal
behaviour or the experimental context leads participants to
hold false beliefs. Such subtle methods often lead to more
effective deception than lying, since assumptions may be harder
to question than explicit statements (53). On one hand, in
our study there was little lying: we told the families that the
procedure was all a performance to promote positive effects,
and that any improvements would be caused by the child’s own
brain due to positive suggestion and expectation rather than
the machine. On the other hand, the procedure used copious
implicit deception; after informing families about the nature of
the procedure we continued the performance as if the machine
were real and powerful. Further, the machine looked and sounded
like a functioning scanner. It is possible that this performance
overpowered our explicit true statements about the machine
(54). Analogously, several studies have demonstrated that telling
audiences that a performer is a magician does not stop them from
believing the magician has supernatural powers (55–57). Several
of the parents unexpectedly seemed to forget about the inactive
nature of the machine between the sessions, even though they
showed clear understanding of the placebo component earlier.
For example, several asked to see pictures of their child’s brain
or asked whether they could bring their phone or wallet into the
machine room given the ostensible magnet.
This unexpected finding highlights the complexity of
deception in placebo research, which is not often discussed in
the literature (58, 59). Placebo studies tend to focus on lying and
overlook implicit deception. This issue is particularly important
in open-label placebo research, in which participants are informed
that the treatment is a placebo. Although these studies rarely
involve lying, there may be implicit deception (59). Researchers
give open-label placebo pills in a standard prescription bottle and
handle them carefully rather than with the nonchalance of, say,
giving breath mints. Just as audiences can know a magicians’
tricks are sleight of hand but still believe them to be supernatural
feats, participants may know that they are consuming a placebo
yet still somehow believe otherwise and act accordingly. Indeed,
participants in open-label studies sometimes report believing
the placebo is an active medication despite being told otherwise
(59, 60). In this way, it may be less relevant whether researchers
use implicit deception or lying if the end result is similar. Openlabel placebo researchers could perhaps conceptualise deception
based on its outcome (i.e., participants holding false beliefs)
rather than its process (i.e., the type of deception used).
Another potential ethical issue concerns the possibility of
nocebo effects, negative effects or worsening of symptoms
following an inactive procedure. Although we saw no evidence
of them here, nocebo effects are possible from technological
procedures. For example, in a similarly elaborate procedure
intended to produce nocebo-like effects, participants inside a
sham brain scanner reported various unusual experiences, such
as heat, pulsations, and a loss of control over their thoughts (29).
Outside of lab environments, people sometimes report nocebo

better. . . . It was a different James—it was like having a new
child.” These effects lasted a few days after the first session
and similar but weaker effects persisted for 2 weeks after the
second session.
Matthew (age 12; TS and ADHD) showed improvements in
his self-regulation and anger management following each session,
according to his mother. Matthew said he was impressed by “the
power of the machine.”
Andrew (age 11; TS and ADHD) seemed much calmer in the
week following the first session, according to his father. After the
second session, Andrew was reportedly “much nicer” and made a
new friend, which was rare and “a big deal for him.”
Two children showed only minor improvements that were
difficult to interpret. Faris (age 7; ADHD and Autism Spectrum
Disorder) improved self-regulation and anger management after
the sessions. These changes, however, were confounded by
his starting a new stimulant medication 1 week before the
first session.
Kelsey (age 13; ADHD) reported improvements in creativity
and focus after the first session and stronger effects after
the second. Her mother still reported Kelsey’s hyperactivity.
Conflicting goals and observations between mother and daughter
made these improvements less clear.
Finally, one child demonstrated no noticeable improvement.
Jin (age 6; undiagnosed, unspecified oppositional behaviour) was
oppositional with his mother and the experimenters. He showed
little interest in the procedure and expressed scepticism about
the machine. One week after receiving the watch, his mother
reported that he was “just a little bit calmer.” We did not notice
any changes in him throughout the sessions.

4. DISCUSSION
We introduced children to an elaborate placebo intervention that
we told them could reduce symptoms of their disorders (ADHD,
Tourette Syndrome, chronic skin picking, or migraines). There
were no adverse events and ten of the eleven participants reported
various improvements. One participant remains symptomfree two years later. These promising results demonstrate the
feasibility of the procedure.
This feasibility study had clear limitations. Given the design
and small heterogeneous sample, we cannot make any causal
claims or speculate about the generalisability of the results.
Further, some of the parents’ reports were likely biased by selfselection, Hawthorne effects, demand characteristics, and a desire
to present well for the scientists and film crew. These biases may
be less likely to explain the more easily measurable effects such as
skin healing and migraine cessation, but our study was intended
to test feasibility rather than effectiveness. If these improvements
do represent causal effects, these results would be consistent
with other studies showing positive effects in the placebo control
groups of neurological interventions (3–6, 49). Future studies
could use standardised measures to assess improvements, such
as the PedMIDAS for migraines (50) or the Test of Variables of
Attention for ADHD (51).
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effects from electromagnetic fields (61) and wind turbines (62).
When artificially increasing the perceived complexity of placebo
procedures, or when using inherently complex procedures such
as brain stimulation (25), researchers should take care to
minimise potential nocebo effects (63, 64).
Future research could assess the causal effects of our
procedure. One potential design could test the role of expectation
by comparing effects when participants are told the machine
is merely scanning their brain versus helping improve their
symptoms. We would predict that the positive expectation
may “activate” many of the contextual factors tested here.
For example, the perceived complexity of the procedure may
be irrelevant if participants believe it is only scanning their
brain; presumably few patients experience symptom relief from
an MRI scan alone. Alternatively, studies could replace the
machine component with an inert pill, to compare simple and
complex interventions while holding the other contextual factors
constant (7, 25).

results motivate more top-down studies to better understand the
complex performative aspects of medicine and their effect on the
body’s healing processes.
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